# Biotech Regulation

Regulatory Renaissance: How New Policy Orders are Unlocking China’s Stem Cell Ambitions

China is implementing a landmark regulatory overhaul to streamline the transition of stem cell research from hospital labs to clinical practice. Centered in Shanghai's Zhangjiang hub, this new policy framework aims to leverage real-world clinical data to establish global leadership in regenerative medicine while enforcing strict ethical and safety standards.